tiprankstipranks
Trending News
More News >
Cipher Pharmaceuticals (TSE:CPH)
TSX:CPH
Canadian Market

Cipher Pharmaceuticals (CPH) Ratios

Compare
91 Followers

Cipher Pharmaceuticals Ratios

TSE:CPH's free cash flow for Q4 2025 was $0.66. For the 2025 fiscal year, TSE:CPH's free cash flow was decreased by $ and operating cash flow was $0.34. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
1.12 1.12 1.94 9.19 4.07
Quick Ratio
0.79 0.79 1.64 8.62 3.84
Cash Ratio
0.30 0.30 0.90 7.58 3.08
Solvency Ratio
1.09 0.92 0.26 3.92 2.85
Operating Cash Flow Ratio
1.19 1.21 0.98 3.05 1.13
Short-Term Operating Cash Flow Coverage
103.53 104.85 0.00 0.00 0.00
Net Current Asset Value
$ -2.21M$ -2.21M$ -21.68M$ 42.76M$ 28.46M
Leverage Ratios
Debt-to-Assets Ratio
0.04 0.04 0.25 <0.01 <0.01
Debt-to-Equity Ratio
0.04 0.04 0.40 <0.01 <0.01
Debt-to-Capital Ratio
0.04 0.04 0.28 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
0.04 0.04 0.28 0.00 0.00
Financial Leverage Ratio
1.24 1.24 1.59 1.07 1.15
Debt Service Coverage Ratio
26.71 18.42 0.00 0.00 0.00
Interest Coverage Ratio
18.05 14.17 0.00 0.00 0.00
Debt to Market Cap
0.02 0.02 0.16 0.00 0.00
Interest Debt Per Share
0.25 0.26 1.64 0.01 0.02
Net Debt to EBITDA
-0.09 -0.12 1.92 -3.42 -2.36
Profitability Margins
Gross Profit Margin
76.50%65.79%72.24%80.77%80.69%
EBIT Margin
32.99%32.73%23.52%48.68%53.45%
EBITDA Margin
43.70%32.73%35.56%54.48%58.23%
Operating Profit Margin
32.99%32.73%23.52%54.48%58.23%
Pretax Profit Margin
34.03%34.02%8.86%59.92%55.52%
Net Profit Margin
54.37%54.17%34.60%96.32%128.83%
Continuous Operations Profit Margin
54.37%54.17%34.60%96.32%128.83%
Net Income Per EBT
159.76%159.23%390.69%160.74%232.04%
EBT Per EBIT
103.16%103.94%37.65%109.99%95.35%
Return on Assets (ROA)
17.63%17.80%7.10%23.69%36.10%
Return on Equity (ROE)
24.23%22.07%11.28%25.31%41.57%
Return on Capital Employed (ROCE)
12.73%12.80%5.50%14.27%18.69%
Return on Invested Capital (ROIC)
12.70%12.78%5.49%14.26%18.66%
Return on Tangible Assets
41.14%41.55%17.41%29.73%48.15%
Earnings Yield
8.97%9.95%4.69%19.15%37.41%
Efficiency Ratios
Receivables Turnover
4.53 4.59 2.41 4.16 3.04
Payables Turnover
1.87 2.75 1.58 0.88 0.97
Inventory Turnover
1.46 2.15 1.60 1.36 1.86
Fixed Asset Turnover
89.16 90.38 49.06 52.64 42.98
Asset Turnover
0.32 0.33 0.21 0.25 0.28
Working Capital Turnover Ratio
10.97 4.75 1.08 0.59 0.90
Cash Conversion Cycle
135.71 116.85 148.44 -60.88 -58.67
Days of Sales Outstanding
80.62 79.53 151.63 87.76 120.08
Days of Inventory Outstanding
250.79 169.90 228.30 267.49 196.76
Days of Payables Outstanding
195.70 132.58 231.50 416.13 375.51
Operating Cycle
331.41 249.43 379.93 355.25 316.85
Cash Flow Ratios
Operating Cash Flow Per Share
1.18 1.19 0.79 0.63 0.42
Free Cash Flow Per Share
1.18 1.19 0.79 0.63 0.42
CapEx Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 1.00 0.99
Dividend Paid and CapEx Coverage Ratio
275.44 1.06K 444.23 111.10 130.56
Capital Expenditure Coverage Ratio
275.44 1.06K 444.23 111.10 130.56
Operating Cash Flow Coverage Ratio
5.44 5.50 0.48 45.32 24.71
Operating Cash Flow to Sales Ratio
0.59 0.59 0.59 0.76 0.51
Free Cash Flow Yield
9.66%10.81%7.93%15.01%14.74%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
11.15 10.05 21.31 5.22 2.67
Price-to-Sales (P/S) Ratio
6.09 5.44 7.37 5.03 3.44
Price-to-Book (P/B) Ratio
2.44 2.22 2.40 1.32 1.11
Price-to-Free Cash Flow (P/FCF) Ratio
10.36 9.25 12.61 6.66 6.78
Price-to-Operating Cash Flow Ratio
10.28 9.24 12.59 6.65 6.73
Price-to-Earnings Growth (PEG) Ratio
0.19 0.08 -0.52 -0.21 0.01
Price-to-Fair Value
2.44 2.22 2.40 1.32 1.11
Enterprise Value Multiple
13.84 16.52 22.65 5.81 3.55
Enterprise Value
306.15M 277.49M 268.74M 66.94M 42.79M
EV to EBITDA
13.83 16.52 22.65 5.81 3.55
EV to Sales
6.05 5.41 8.05 3.16 2.07
EV to Free Cash Flow
10.29 9.18 13.78 4.19 4.08
EV to Operating Cash Flow
10.25 9.17 13.75 4.18 4.05
Tangible Book Value Per Share
1.45 1.44 0.25 2.47 1.82
Shareholders’ Equity Per Share
4.98 4.94 4.14 3.16 2.55
Tax and Other Ratios
Effective Tax Rate
-0.60 -0.59 -2.91 -0.61 -1.32
Revenue Per Share
2.00 2.01 1.35 0.83 0.82
Net Income Per Share
1.09 1.09 0.47 0.80 1.06
Tax Burden
1.60 1.59 3.91 1.61 2.32
Interest Burden
1.03 1.04 0.38 1.23 1.04
Research & Development to Revenue
<0.01 0.00 0.00 <0.01 <0.01
SG&A to Revenue
0.22 0.00 0.32 0.22 0.19
Stock-Based Compensation to Revenue
0.02 0.00 0.03 0.06 0.02
Income Quality
1.08 1.09 1.69 0.78 0.40
Currency in USD